Neuroprogressive and Dementia

Dementia is one of the foremost public health challenges worldwide. As a consequence of improved healthcare and better standards of living more people are living for longer. This means in Scotland that the number of people with dementia is expected to double between 2011 and 2031.

At the same time, neuroprogressive diseases including Motor Neurone Disease, Parkinson’s Disease, Huntington’s Disease, and Multiple Sclerosis are increasingly understood to have commonality in underlying causes, patient experience, symptoms and their management.

To advance understanding of the diseases and new treatments, inter-disciplinary research is crucial. Supported by the NRS Neuroprogressive and Dementia Network a wide range of research studies are conducted within the NHS and Care Home settings including:

Research into the underlying mechanisms and causes
Prevention
New symptoms
Disease-modifying treatments
Better care

Recently, our Strategic Manager Dr Emma Law, and our Network Manager Jacqui Kerr spoke to the Dementia Researcher channel about how the network offers world-class support to researchers across Scotland and beyond, helping to connect people living with dementia and neuroprogressive diseases with cutting-edge research.